CDC Website CDC Website

To Join the NPIN community or

Home » Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

COVID-19 Information |

For COVID-19 testing information please visit: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Directly contact organizations to find out about changes to services or hours.

Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

Centers for Disease Control and Prevention, Division of Tuberculosis Elimination
Thumbnail image of Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
This report summarizes updated recommendations for managing the drug-drug interactions that occur when using antiretroviral therapy during TB treatment. Changes from previous versions of these guidelines include an effort to obtain and summarize the clinical experience of using specific antiretroviral regimens during TB treatment (not just pharmacokinetic data), a table summarizing the clinical experience with key antiretroviral regimens and providing recommended regimens (Table 1), and sections on treatment for special populations (young children, pregnant women, patients with drug-resistant TB). Drug-drug interaction data are included for antiretroviral drugs that have been approved or are currently available through expanded access programs in the United States.
Author
Disease
Topics/Subjects
Year of Publication
2007
Format
Physical Description
20 p.: col.; refs., tables.

Last Updated Date: 

1/17/14

Publication ID: 

34680